Holen Sie sich die Stockscreener-App
81.02
0.14%
-0.11
Handel nachbörslich:
81.02
Schlusskurs vom Vortag:
$81.13
Offen:
$81.06
24-Stunden-Volumen:
1.30M
Relative Volume:
1.34
Marktkapitalisierung:
$6.84B
Einnahmen:
$1.31B
Nettoeinkommen (Verlust:
$215.20M
KGV:
32.90
EPS:
2.4627
Netto-Cashflow:
$408.32M
1W Leistung:
+4.13%
1M Leistung:
+2.69%
6M Leistung:
-13.57%
1J Leistung:
-4.23%
1-Tages-Spanne:
$79.79
$82.03
1-Wochen-Bereich:
$77.72
$83.36
52-Wochen-Spanne:
$72.76
$116.65
Healthequity Inc Stock (HQY) Company Profile
Firmenname
Healthequity Inc
Sektor
Branche
Telefon
801-727-1000
Adresse
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, TEM, BTSG, MMED
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQY
Healthequity Inc
|
81.02 | 6.84B | 1.31B | 215.20M | 408.32M | 2.4627 |
VEEV
Veeva Systems Inc
|
184.07 | 30.26B | 3.20B | 908.91M | 1.42B | 5.4155 |
TEM
Tempus Ai Inc
|
46.96 | 8.40B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
41.21 | 7.92B | 12.91B | 104.80M | 394.69M | 0.8769 |
MMED
Minimed Group Inc
|
16.57 | 4.65B | 0 | 0 | 0 | 0.00 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-05-22 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-03-25 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-04-02 | Bestätigt | JP Morgan | Overweight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-10-21 | Hochstufung | Goldman | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-12 | Eingeleitet | Goldman | Sell |
| 2022-04-11 | Eingeleitet | Wells Fargo | Overweight |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-03-30 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-12-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-09-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-07-02 | Eingeleitet | Stephens | Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-01-07 | Eingeleitet | BTIG Research | Neutral |
| 2020-12-08 | Bestätigt | Barrington Research | Outperform |
| 2020-12-02 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-14 | Eingeleitet | Guggenheim | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-03-17 | Bestätigt | Barrington Research | Outperform |
| 2019-10-07 | Eingeleitet | Goldman | Neutral |
| 2019-09-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-07-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-06-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-03-01 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-07 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-12-06 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-05-23 | Eingeleitet | BofA/Merrill | Buy |
| 2018-04-24 | Fortgesetzt | JP Morgan | Overweight |
| 2018-03-20 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-06 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Healthequity Inc Aktie (HQY) Neueste Nachrichten
HealthEquity Inc stock faces scrutiny amid slowing HSA growth and rising competition in US benefits - AD HOC NEWS
HealthEquity Q4 Earnings Rise; Raises 2027 Outlook - Value The Markets
HealthEquity price target raised to $128 from $120 at Deutsche Bank - TipRanks
HealthEquity Analysts Cut Their Forecasts After Q4 Results - Sahm
HealthEquity analysts cut their forecasts after Q4 results - MSN
HealthEquity, Inc. (NASDAQ:HQY) Q4 2026 earnings call transcript - MSN
HQY: Deutsche Bank Raises Price Target, Maintains Buy Rating | H - GuruFocus
HealthEquity (NASDAQ:HQY) Price Target Raised to $128.00 at Deutsche Bank Aktiengesellschaft - MarketBeat
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY) and Intuitive Surgical (ISRG) - The Globe and Mail
Discipline and Rules-Based Execution in HQY Response - Stock Traders Daily
Deutsche Bank Adjusts HealthEquity Price Target to $128 From $120, Maintains Buy Rating - marketscreener.com
Analysts’ Top Healthcare Picks: Healthequity (HQY), AbSci (ABSI) - The Globe and Mail
BMO Maintains Market Perform on HealthEquity (HQY) March 18, 2026 - Meyka
HealthEquity Inc. Earnings Call Highlights Profitable Growth - TipRanks
Reasons to hold HealthEquity stock in your portfolio for now - MSN
HealthEquity (HQY) Margin Expansion To 16.4% Tests Bearish Cost Narratives - simplywall.st
HealthEquity Q4 Earnings Call Highlights - MarketBeat
New health sharing program has seen 236% growth rate, with high hopes for 2026 - AOL.com
HealthEquity (HQY): Analyst Lowers Price Target Amid Maintained Rating | HQY Stock News - GuruFocus
JP Morgan Maintains Rating, Lowers Price Target for HealthEquity (HQY) | HQY Stock News - GuruFocus
HealthEquity stock price target lowered to $100 by RBC on yield outlook - Investing.com India
JPMorgan Chase & Co. Issues Pessimistic Forecast for HealthEquity (NASDAQ:HQY) Stock Price - MarketBeat
HealthEquity (NASDAQ:HQY) Given New $110.00 Price Target at Barrington Research - MarketBeat
HQY: RBC Capital Maintains Outperform Rating, Lowers Price Targe - GuruFocus
HealthEquity, Inc. 2026 Annual Report: Technology-Driven HSA Solutions, Competitive Strategy, AI Innovation, and Risk Factors 232527293940 - Minichart
BMO reiterates HealthEquity stock rating on strong quarter, AI progress - Investing.com UK
BMO reiterates HealthEquity stock rating on strong quarter, AI progress By Investing.com - Investing.com India
Royal Bank Of Canada Has Lowered Expectations for HealthEquity (NASDAQ:HQY) Stock Price - MarketBeat
HealthEquity, Inc. Q4 2026 Earnings Call Summary - Yahoo Finance
HealthEquity (HQY) Q4 EPS Plunges 42.6% YoY to $0.95, Misses Estimates Despite $334.6M Revenue Beat - AlphaStreet
RBC Cuts Price Target on HealthEquity to $100 From $110, Keeps Outperform Rating - marketscreener.com
Faithward Advisors Boosts HealthEquity Stake to $4.41 Million - National Today
Faithward Advisors LLC Takes $4.41 Million Position in HealthEquity, Inc. $HQY - MarketBeat
HQY SEC FilingsHealthequity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Crown Advisors Management Inc. Invests $1.90 Million in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade) - Seeking Alpha
Healthequity Inc earnings beat by $0.05, revenue topped estimates - Investing.com Australia
HealthEquity (HQY) beats Q4 earnings and revenue estimates - MSN
Decoding HealthEquity Inc (HQY): A Strategic SWOT Insight - GuruFocus
HealthEquity Inc (HQY) Q4 2026 Earnings Call Highlights: Record HSA Growth and Strong Financial ... By GuruFocus - Investing.com Canada
HealthEquity Inc (HQY) Q4 2026 Earnings Call Highlights: Record HSA Growth and Strong Financial Performance - GuruFocus
HealthEquity (HQY) Fourth Quarter 2026 Earnings Call Transcript - Bitget
HealthEquity (NASDAQ:HQY) Issues Quarterly Earnings Results - MarketBeat
HealthEquity 2026 Earnings Report: Q4 and Full Year ResultsNews and Statistics - IndexBox
HealthEquity (HQY) Q4 2026 Earnings Transcript - The Globe and Mail
Earnings call transcript: HealthEquity Q4 2026 beats EPS & revenue forecasts - Investing.com
HQY: Record HSA growth, margin expansion, and raised FY27 guidance highlight strong performance - TradingView
Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
HealthEquity (HQY) Surpasses Revenue Expectations and Elevates F - GuruFocus
HQY Projects Strong Financial Performance for FY27 - GuruFocus
Healthequity Inc reports results for the quarter ended January 31Earnings Summary - TradingView
Finanzdaten der Healthequity Inc-Aktie (HQY)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):